Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 526–540 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2671 Neuroviruses Comprehensive Panel Qualitative PCR Test This test detects the presence of genetic material from specific neurotropic viruses in cerebrospinal fluid.	Cerebrospinal Fluid (CSF)	3 working days (sample received by Thursday 11 am, report by Saturday)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Viral nucleic acids (DNA and RNA)", "Presence of specific neurotropic pathogens"] Parameters [] Preparation ["Fasting is not required", "Follow neurologist instructions regarding medication management"] Indications ["Suspected viral meningitis or encephalitis", "Diagnosis of neurotropic viral infections", "Guiding antiviral therapy", "Evaluating neurological symptoms of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 88507-1 ICD-10: B00.4, B01.11, B02.0, B25.8, A87.0 Clinical summary This test detects the presence of genetic material from specific neurotropic viruses in cerebrospinal fluid.
TEST-2645 Neuroviruses Panel Qualitative PCR Test This test detects the presence of nucleic acids from specific viruses known to cause central nervous system infections.	Cerebrospinal fluid (CSF) and/or blood	2–3 working days (Mon/Thu sample)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Viral nucleic acids (DNA/RNA)", "Presence of specific neurotropic viruses"] Parameters [] Preparation ["No special preparation is required"] Indications ["Suspected neurological infection", "Diagnosis of viral encephalitis or meningitis"] Measurement technique Confirm with laboratory Codes LOINC: 88549-1 ICD-10: A85.8, B00.4, B01.0, B97.1 Clinical summary This test detects the presence of nucleic acids from specific viruses known to cause central nervous system infections.
TEST-2758 Next-Generation Sequencing (NGS) Comprehensive Panel for Leber Congenital Amaurosis (LCA) Test This test identifies genetic variants in known LCA-associated genes to diagnose the cause of Leber Congenital Amaurosis.	Whole blood	45 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants", "Small insertions and deletions", "Copy-number variations", "Deep intronic hotspots"] Parameters [] Preparation ["No specific fasting required.", "Continue all prescribed ophthalmic medications unless instructed otherwise by the treating ophthalmologist."] Indications ["Diagnosis of Leber Congenital Amaurosis (LCA)", "Assessment of eligibility for gene therapy", "Reproductive counseling", "Carrier status determination"] Measurement technique Confirm with laboratory Codes LOINC: 101023-3 ICD-10: H35.52 Clinical summary This test identifies genetic variants in known LCA-associated genes to diagnose the cause of Leber Congenital Amaurosis.
TEST-2738 Next-Generation Sequencing Panel for Charcot-Marie-Tooth Disease & Sensory Neuropathies Test This test identifies pathogenic genetic variants in over 60 genes associated with Charcot-Marie-Tooth disease and hereditary sensory neuropathies.	Peripheral whole blood (10 mL in two EDTA tubes)	40 working days from sample receipt	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single nucleotide variants", "Small insertions and deletions", "Copy number variations"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of all current medications and supplements", "Inform phlebotomist of any blood transfusion within the past 4 weeks"] Indications ["Suspected Charcot-Marie-Tooth disease", "Suspected hereditary sensory neuropathy", "Family history of CMT or related disorders", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 101123-3 ICD-10: G60.0 Clinical summary This test identifies pathogenic genetic variants in over 60 genes associated with Charcot-Marie-Tooth disease and hereditary sensory neuropathies.
TEST-2744 Next‑Generation Sequencing (NGS) for Optic Atrophy Panel Test This test identifies genetic mutations in multiple genes associated with hereditary optic atrophy.	Whole blood	45 calendar days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in genes like OPA1, OPA3, MFN2, WFS1, MT-ND4, and 35+ additional genes", "Exons and flanking splice sites of implicated genes"] Parameters [] Preparation ["No fasting required", "Complete and sign Whole Exome Sequencing Consent Form (Form 37)"] Indications ["Suspected hereditary optic atrophy", "Need for molecular diagnosis to guide prognosis", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 82319-1 ICD-10: H47.20, H47.2 Clinical summary This test identifies genetic mutations in multiple genes associated with hereditary optic atrophy.
TEST-2713 Next‑Generation Sequencing Panel for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy Test This test identifies genetic variants associated with Bethlem myopathy, myofibrillar myopathy, and Ullrich congenital muscular dystrophy using Next-Generation Sequencing.	Whole blood	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in associated genes", "Coding exons and flanking intronic regions"] Parameters [] Preparation [] Indications ["Suspected diagnosis of Bethlem myopathy", "Suspected diagnosis of Myofibrillar Myopathy", "Suspected diagnosis of Ullrich Muscular Dystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.0 Clinical summary This test identifies genetic variants associated with Bethlem myopathy, myofibrillar myopathy, and Ullrich congenital muscular dystrophy using Next-Generation Sequencing.
TEST-1975 NF1 Gene Neurofibromatosis Type 1 Genetic Test This test evaluates the entire NF1 gene for pathogenic variants associated with Neurofibromatosis Type 1.	Peripheral whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in NF1 gene", "Small insertions/deletions in NF1 gene", "Copy number variations in NF1 gene"] Parameters [] Preparation [] Indications ["Confirmation of clinical suspicion of NF1", "Assessment of familial risk", "Guidance for oncology/neurology surveillance", "Predictive testing for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 81349-5 ICD-10: Q85.0 Clinical summary This test evaluates the entire NF1 gene for pathogenic variants associated with Neurofibromatosis Type 1.
TEST-1968 NF2 Gene Neurofibromatosis Type 2 Genetic Test This genetic test evaluates the entire coding region of the NF2 gene for pathogenic mutations associated with Neurofibromatosis type 2.	Whole Blood (5 mL) or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NF2 gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["Provide a detailed three-generation family pedigree", "Avoid heavy physical exertion for 24 hours before blood collection", "Avoid alcohol for 24 hours before blood collection"] Indications ["Diagnosis of Neurofibromatosis type 2", "Risk assessment for individuals with family history", "Pre-symptomatic testing", "Cascade screening for family members"] Measurement technique Confirm with laboratory Codes LOINC: 21655-2 ICD-10: Q85.02 Clinical summary This genetic test evaluates the entire coding region of the NF2 gene for pathogenic mutations associated with Neurofibromatosis type 2.
TEST-4590 NGF Gene HSAN5 Next-Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants within the NGF gene associated with Hereditary Sensory and Autonomic Neuropathy Type 5 (HSAN5).	Peripheral whole blood (EDTA, 3–5 mL) or FTA card dried blood spot	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NGF gene sequence", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting required.", "No dietary modification needed.", "No medication adjustment needed unless directed by physician."] Indications ["Suspected Hereditary Sensory and Autonomic Neuropathy Type 5 (HSAN5)", "Congenital insensitivity to pain", "Family history of HSAN5"] Measurement technique Confirm with laboratory Codes LOINC: 81307-7 ICD-10: G60.8, Z13.7 Clinical summary This test identifies pathogenic variants within the NGF gene associated with Hereditary Sensory and Autonomic Neuropathy Type 5 (HSAN5).
TEST-462 NGS Whole Exome for Couple Test This test assesses the protein-coding regions of the genome in both partners to identify shared genetic variants associated with recessive and X-linked disorders.	Peripheral whole blood	3–4 weeks	6,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Protein-coding regions of the genome (exome)", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation [] Indications ["Couples planning pregnancy", "Family history of genetic disorders", "Consanguineous marriages", "Previous affected pregnancies"] Measurement technique Confirm with laboratory Codes LOINC: 101297-1 ICD-10: Z13.89 Clinical summary This test assesses the protein-coding regions of the genome in both partners to identify shared genetic variants associated with recessive and X-linked disorders.
TEST-3702 NGSNeuro Genetic Test for Neurological Disorders This test evaluates over 200 genes linked to hereditary neurological disorders using next-generation sequencing.	Whole blood (EDTA), Dried blood spot (FTA card), or extracted DNA	3–4 weeks from sample receipt	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in over 200 neuro-specific genes", "Genetic predisposition to hereditary neurological disorders"] Parameters [] Preparation ["Mandatory genetic counselling session required", "No dietary or medication restrictions unless advised by a doctor", "Continue all prescribed treatments"] Indications ["Diagnosis of hereditary neurological disorders", "Risk assessment for individuals with family history", "Guiding treatment and management strategies"] Measurement technique Confirm with laboratory Codes LOINC: 81314-6 ICD-10: Z13.78 Clinical summary This test evaluates over 200 genes linked to hereditary neurological disorders using next-generation sequencing.
TEST-701 Nipah Virus RNA Detection Qualitative Test This test detects the presence of Nipah virus RNA in patient samples, indicating an active infection.	Whole blood, serum, plasma, respiratory secretions (nasopharyngeal/throat swabs), urine	5–7 business days from sample receipt	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Nipah virus RNA"] Parameters [] Preparation [] Indications ["Suspected Nipah virus infection", "Exposure to bats or pigs in endemic areas", "Neurological symptoms", "Epidemiological link to a known outbreak"] Measurement technique Confirm with laboratory Codes LOINC: 72963-1 ICD-10: B59.9 Clinical summary This test detects the presence of Nipah virus RNA in patient samples, indicating an active infection.
TEST-6064 NKX2‑2 Gene Sequencing for Maturity‑Onset Diabetes of the Young (MODY) Test This test evaluates the NKX2-2 gene for pathogenic variants associated with Maturity-Onset Diabetes of the Young (MODY).	Whole Blood (EDTA) or Buccal Swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NKX2-2 gene sequence", "Pathogenic variants in NKX2-2"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Diagnosis of MODY", "Differentiation from Type 1/Type 2 diabetes", "Personalized therapy guidance", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 81234-5 ICD-10: E11.8 Clinical summary This test evaluates the NKX2-2 gene for pathogenic variants associated with Maturity-Onset Diabetes of the Young (MODY).
TEST-4592 NOD2 Gene (Early-Onset Sarcoidosis) Genetic Test This test detects pathogenic mutations in the NOD2 gene associated with Blau syndrome and familial sarcoidosis.	Peripheral whole blood, FTA card, or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the NOD2 gene", "Copy Number Variations (CNV) in the NOD2 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Blau syndrome", "Diagnosis of familial sarcoidosis", "Genetic risk assessment in families with sarcoidosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-1 ICD-10: M04.8, D86.9 Clinical summary This test detects pathogenic mutations in the NOD2 gene associated with Blau syndrome and familial sarcoidosis.
TEST-1951 NPM1 Gene Exon 11 Sequencing (NGS) Test This test identifies mutations in the NPM1 gene, specifically within exon 11, using Next Generation Sequencing.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 Weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Point mutations in NPM1 gene exon 11", "Small insertions/deletions in NPM1 gene exon 11", "Variant Allele Frequency (VAF)"] Parameters [] Preparation [] Indications ["Confirmed or suspected diagnosis of AML", "Confirmed or suspected diagnosis of Myeloid Sarcoma", "Confirmed or suspected diagnosis of Clonal Cytopenia of Undetermined Significance"] Measurement technique Confirm with laboratory Codes LOINC: 94438-0 ICD-10: C92.0 Clinical summary This test identifies mutations in the NPM1 gene, specifically within exon 11, using Next Generation Sequencing.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories